A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy
Clinical trial NCT04161911 · COMPLETED
Trial details
- NCT number
- NCT04161911
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-29
- Primary completion
- 2018-11-15
- Enrollment
- 1426
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.